Breaking News Instant updates and real-time market news.

2022-04-29 07:53:17 ROKU Roku $91.55 / +6.715 (+7.92%) 07:53 04/29/22 04/29 07:53 04/29/22 07:53	Roku price target lowered to $190 from $230 at Stephens Stephens analyst Nicholas Zangler lowered the firm's price target on Roku to $190 from $230, noting that ad-tech valuations remain under significant pressure given macroeconomic uncertainties, and keeps an Overweight rating on the shares following the company's Q1 report. Active accounts increased by 1.2M sequentially to 61.3M, in-line with consensus, while Platform revenues beat the Street view, Zangler noted. While Q2 guidance came in below consensus "across all metrics," Roku maintained its full year revenue guidance for 35% growth, Zangler added.	09 Jun 13 Jun

2022-04-29 07:53:17

ROKU

Roku

$91.55 / +6.715 (+7.92%)

07:53

04/29/22

04/29

07:53

04/29/22

07:53

Roku price target lowered to $190 from $230 at Stephens

Stephens analyst Nicholas Zangler lowered the firm's price target on Roku to $190 from $230, noting that ad-tech valuations remain under significant pressure given macroeconomic uncertainties, and keeps an Overweight rating on the shares following the company's Q1 report. Active accounts increased by 1.2M sequentially to 61.3M, in-line with consensus, while Platform revenues beat the Street view, Zangler noted. While Q2 guidance came in below consensus "across all metrics," Roku maintained its full year revenue guidance for 35% growth, Zangler added.

09
Jun
13
Jun

OTHER BREAKING NEWS FROM THE FLY

Initiation	Haleon initiated with a Sector Perform at RBC Capital » 12:01 08/15/22 08/15 12:01 08/15/22 12:01 HLN Haleon $6.35 / -0.345 (-5.15%) , PFE Pfizer $49.55 / -0.55 (-1.10%) , GSK GSK plc $34.55 / -1.495 (-4.15%) RBC Capital analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options HLN PFE GSK HLN Haleon $6.35 / -0.345 (-5.15%) 08/11/22 Haleon says it is not a party to any Zantac claims 08/11/22 GSK says no new 'material developments' related to Zantac litigation 07/18/22 GSK plc announces completion of demerger of Haleon PFE Pfizer $49.55 / -0.55 (-1.10%) 09:31 Today Pfizer Chairman, CEO Bourla tests positive for COVID-19 08/12/22 Pfizer reports 'positive' results from Phase 3 study of 20vPnC 08/11/22 Haleon says it is not a party to any Zantac claims 08/11/22 Sanofi says 'confident in its legal defenses' related to U.S. Zantac litigation GSK GSK plc $34.55 / -1.495 (-4.15%) 09:49 Today Ideaya Biosciences down 34% after GSK waived option on IDE397 08/11/22 Haleon says it is not a party to any Zantac claims 08/11/22 GSK says no new 'material developments' related to Zantac litigation 08/11/22 Sanofi says 'confident in its legal defenses' related to U.S. Zantac litigation HLN PFE GSK HLN Haleon $6.35 / -0.345 (-5.15%) 08/12/22 JPMorgan Sanofi may not be liable for any Zantac litigation damages, says JPMorgan 08/11/22 JPMorgan Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan 08/11/22 Deutsche Bank Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank 07/29/22 Deutsche Bank Haleon initiated with a Hold at Deutsche Bank PFE Pfizer $49.55 / -0.55 (-1.10%) 08/14/22 BofA Pfizer Prevnar-20 miss on co-primary endpoint could help Vaxcyte, says BofA 08/12/22 JPMorgan Sanofi may not be liable for any Zantac litigation damages, says JPMorgan 08/11/22 JPMorgan Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan 08/11/22 Deutsche Bank Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank GSK GSK plc $34.55 / -1.495 (-4.15%) 10:20 Today Stifel Ideaya Biosciences downgraded to Hold at Stifel after GSK waives IDE397 opt-in 08/12/22 JPMorgan Sanofi may not be liable for any Zantac litigation damages, says JPMorgan 08/11/22 JPMorgan Perrigo, Pfizer appear to have manageable Zantac exposure, says JPMorgan 08/11/22 Deutsche Bank Zantac cases likely a short-term headwind for GSK, Sanofi, says Deutsche Bank PFE GSK PFE Pfizer $49.55 / -0.55 (-1.10%) 07/28/22 Pfizer raises FY22 adjusted EPS view to $6.30-$6.45 from $6.25-$6.45 07/28/22 Pfizer reports Q2 adjusted EPS $2.04, consensus $1.80 07/27/22 Notable companies reporting before tomorrow's open 07/27/22 Notable companies reporting before tomorrow's open GSK GSK plc $34.55 / -1.495 (-4.15%) 07/27/22 GSK plc reports Q2 adjusted EPS 34.7p vs. 28.2p last year 04/27/22 GlaxoSmithKline reaffirms FY22 sales growth between 5%-7% at CER 04/27/22 GlaxoSmithKline reports Q1 adjusted EPS 32.8p vs. 22.9p last year 04/13/22 GlaxoSmithKline backs FY22 revenue view up 5%-7% at CER, consensus $47.34B HLN PFE GSK HLN Haleon $6.35 / -0.345 (-5.15%) 08/11/22 GSK, Sanofi weakness related to Zantac litigation worries, Bloomberg reports PFE Pfizer $49.55 / -0.55 (-1.10%) 08/05/22 Pfizer in advanced talks to buy Global Blood for about $5B, WSJ reports 08/05/22 Pfizer in talks to buy Global Blood Therapeutics for about $5B, WSJ says 07/18/22 GSK CEO says split will help deal with 'perennial underperformance,' FT reports 06/28/22 FDA panel recommends omicron update for COVID vaccine boosters, CNBC says GSK GSK plc $34.55 / -1.495 (-4.15%) 08/11/22 GSK, Sanofi weakness related to Zantac litigation worries, Bloomberg reports 07/18/22 GSK CEO says split will help deal with 'perennial underperformance,' FT reports 06/27/22 GSK's Haleon chooses Citi, UBS as spinoff brokers, Bloomberg says 06/27/22 GSK's Haleon chooses Citi, UBS as spinoff brokers, Bloomberg says HLN PFE GSK HLN Haleon $6.35 / -0.345 (-5.15%) 08/11/22 Renewed Zantac litigation concerns sinking these big-cap drugmakers 08/11/22 What You Missed On Wall Street This Morning 07/29/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/18/22 What You Missed On Wall Street This Morning PFE Pfizer $49.55 / -0.55 (-1.10%) 08/11/22 Renewed Zantac litigation concerns sinking these big-cap drugmakers 08/08/22 What You Missed On Wall Street On Monday 08/08/22 What You Missed On Wall Street This Morning 08/08/22 Fly Intel: Pre-market Movers GSK GSK plc $34.55 / -1.495 (-4.15%) 08/11/22 What You Missed On Wall Street On Thursday 08/11/22 Renewed Zantac litigation concerns sinking these big-cap drugmakers 08/11/22 What You Missed On Wall Street This Morning 08/09/22 What You Missed On Wall Street On Tuesday 09/10/22 ESMO Congress 2022 HLN PFE GSK HLN Haleon $6.35 / -0.345 (-5.15%) 07/27/22 new option listings and one option delisting on July 27th PFE Pfizer $49.55 / -0.55 (-1.10%) 08/11/22 Pfizer call volume above normal and directionally bullish 07/28/22 Unusually active option classes on open July 28th 06/30/22 Early notable gainers among liquid option names on June 30th 05/20/22 Early notable gainers among liquid option names on May 20th GSK GSK plc $34.55 / -1.495 (-4.15%) 09:40 Today Unusually active option classes on open August 15th 08/12/22 Unusually active option classes on open August 12th 08/11/22 GSK plc (ADR) call volume above normal and directionally bullish 08/10/22 GSK plc (ADR) call volume above normal and directionally bullish
Recommendations	Russel Metals price target raised to C$42 from C$39 at RBC Capital » 12:01 08/15/22 08/15 12:01 08/15/22 12:01 RUSMF Russel Metals $23.20 / +0.67 (+2.97%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research RUSMF Russel Metals $23.20 / +0.67 (+2.97%) 11:09 Today Scotiabank Russel Metals price target lowered to C$37.50 from C$38.50 at Scotiabank 08/12/22 BMO Capital Russel Metals price target lowered to C$32 from C$36 at BMO Capital 08/12/22 Stifel Russel Metals price target raised to C$40 from C$34 at Stifel 07/18/22 RBC Capital Russel Metals price target lowered to C$39 from C$45 at RBC Capital
Conference/Events	Cantor Fitzgerald equity derivative analyst has analyst/industry conference call » 12:01 08/15/22 08/15 12:01 08/15/22 12:01 Equity Derivatives and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Recommendations	Northland Power price target raised to C$48 from C$46 at RBC Capital » 12:01 08/15/22 08/15 12:01 08/15/22 12:01 NPIFF Northland Power $35.76 / +1.22 (+3.53%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research NPIFF Northland Power $35.76 / +1.22 (+3.53%) 07/11/22 Northland Power signs corporate power purchase agreement 05/17/22 Northland Power announces amendment to diversity policy 05/09/22 BNP Paribas, Northland Power partner with Export Development Canada 04/27/22 Northland Power launches refreshed brand NPIFF Northland Power $35.76 / +1.22 (+3.53%) 11:30 Today National Bank Northland Power price target raised to C$49 from C$47 at National Bank 11:04 Today Scotiabank Northland Power price target raised to C$51 from C$46.25 at Scotiabank 10:53 Today TD Securities Northland Power price target raised to C$55 from C$47 at TD Securities 08/12/22 BMO Capital Northland Power price target raised to C$50 from C$44 at BMO Capital
Recommendations	MDA Ltd price target lowered to C$13 from C$15 at RBC Capital » 12:01 08/15/22 08/15 12:01 08/15/22 12:01 MDALF MDA Ltd / + RBC Capital analyst Ken… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research MDALF MDA Ltd / + 07/07/22 MDA appoints Johnson as Vice President of RSO MDALF MDA Ltd / + 05/12/22 BMO Capital MDA Ltd price target lowered to C$11 from C$13 at BMO Capital 05/12/22 Canaccord MDA Ltd price target lowered to C$15 from C$20 at Canaccord 03/18/22 Canaccord MDA Ltd price target lowered to C$20 from C$21 at Canaccord 03/18/22 RBC Capital MDA Ltd price target raised to C$15 from C$13 at RBC Capital
Recommendations	H&R REIT price target raised to C$15.75 from C$15 at RBC Capital » 12:00 08/15/22 08/15 12:00 08/15/22 12:00 HRUFF H&R REIT $10.86 / +0.21 (+1.97%) RBC Capital analyst Matt… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HRUFF H&R REIT $10.86 / +0.21 (+1.97%) 11:37 Today National Bank H&R REIT price target raised to C$16.50 from C$15.25 at National Bank 07/20/22 National Bank H&R REIT price target lowered to C$15.25 from C$18.50 at National Bank 05/18/22 Scotiabank H&R REIT price target raised to C$16.50 from C$15.25 at Scotiabank 05/16/22 BMO Capital H&R REIT price target raised to C$18 from C$16 at BMO Capital
Hot Stocks	Redwire falls -9.9% » 12:00 08/15/22 08/15 12:00 08/15/22 12:00 RDW Redwire $3.57 / -0.35 (-8.93%) Redwire is down -9.9%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options RDW Redwire $3.57 / -0.35 (-8.93%) 07/01/22 Redwire added to broad-market Russell 3000 Index 06/07/22 Redwire awarded contract to manufacture link-16 antennas 06/01/22 Redwire CFO Bill Read to transition out of role, Jonathan Baliff to succeed 05/03/22 Redwire names Al Tadros Chief Technology Officer RDW Redwire $3.57 / -0.35 (-8.93%) 09/28/21 Fly Intel: Top five analyst initiations 09/28/21 Jefferies Redwire initiated with a Buy at Jefferies RDW Redwire $3.57 / -0.35 (-8.93%) 05/12/22 Redwire reports Q1 EPS (28c) vs. (21c) last year 03/31/22 Redwire sees FY22 revenue $165M-$195M vs. $96.8M in FY21 03/31/22 Redwire reports Q4 EPS (55c) vs. (6c) last year RDW Redwire $3.57 / -0.35 (-8.93%) 04/01/22 What You Missed On Wall Street On Friday 04/01/22 What You Missed On Wall Street This Morning 03/31/22 Fly Intel: After-Hours Movers RDW Redwire $3.57 / -0.35 (-8.93%) 03/23/22 Largest borrow rate increases among liquid names 03/15/22 Largest borrow rate increases among liquid names 03/14/22 Largest borrow rate increases among liquid names 03/11/22 Largest borrow rate increases among liquid names
Hot Stocks	Turquoise Hill falls -10.4% » 12:00 08/15/22 08/15 12:00 08/15/22 12:00 TRQ Turquoise Hill $23.56 / -2.68 (-10.21%) Turquoise Hill is down… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly TRQ Turquoise Hill $23.56 / -2.68 (-10.21%) 10:00 Today Turquoise Hill falls -14.1% 09:47 Today Turquoise Hill falls -17.0% 09:19 Today Turquoise Hill down 17% after terminating review to be bought by Rio Tinto 06:37 Today Rio Tinto reiterates proposal for acquisition of Turquoise Hill TRQ Turquoise Hill $23.56 / -2.68 (-10.21%) 08/08/22 Canaccord Turquoise Hill price target lowered to C$42 from C$44 at Canaccord 08/08/22 TD Securities Turquoise Hill price target lowered to C$38 from C$40 at TD Securities 08/08/22 Canaccord Turquoise Hill price target lowered to C$42 from C$44 at Canaccord 07/14/22 Canaccord Turquoise Hill price target lowered to C$44 from C$45 at Canaccord TRQ Turquoise Hill $23.56 / -2.68 (-10.21%) 08/04/22 Turquoise Hill backs FY22 copper production guidance 08/04/22 Turquoise Hill reports Q2 EPS 51c, consensus 36c 05/10/22 Turquoise Hill reports Q1 EPS $1.37, consensus 28c TRQ Turquoise Hill $23.56 / -2.68 (-10.21%) 04/19/22 Fly Intel: After-Hours Movers 03/14/22 What You Missed On Wall Street On Monday 03/14/22 What You Missed On Wall Street This Morning
Hot Stocks	SmartRent falls -13.2% » 12:00 08/15/22 08/15 12:00 08/15/22 12:00 SMRT SmartRent $3.32 / -0.495 (-12.99%) SmartRent is down -13.2%,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly SMRT SmartRent $3.32 / -0.495 (-12.99%) 08/12/22 SmartRent falls -32.7% 08/12/22 SmartRent falls -26.6% 08/12/22 SmartRent falls -19.5% 08/11/22 SmartRent falls 28% to $4.02 after Q2 earnings miss and guidance cut SMRT SmartRent $3.32 / -0.495 (-12.99%) 08/12/22 Cantor Fitzgerald SmartRent price target lowered to $5.25 from $6.00 at Cantor Fitzgerald 07/22/22 Cantor Fitzgerald SmartRent assumed with an Overweight at Cantor Fitzgerald 07/19/22 Keefe Bruyette Bain Capital sold 5% of stake in SmartRent, says Keefe Bruyette 05/25/22 Compass Point Compass Point starts SmartRent at Buy, sees 'exponential growth potential' SMRT SmartRent $3.32 / -0.495 (-12.99%) 08/11/22 SmartRent cuts FY22 revenue view to $155M-$180M from $220M-$250M 08/11/22 SmartRent sees Q3 revenue $43M-$47M, consensus $75.4M 08/11/22 SmartRent reports Q2 EPS (13c), consensus (11c) 05/11/22 SmartRent sees FY22 revenue $220M-$250M, consensus $238.1M SMRT SmartRent $3.32 / -0.495 (-12.99%) 08/12/22 What You Missed On Wall Street On Friday 08/12/22 What You Missed On Wall Street This Morning 08/11/22 Fly Intel: After-Hours Movers 05/11/22 Fly Intel: After-Hours Movers
Hot Stocks	Enhabit rises 16.0% » 12:00 08/15/22 08/15 12:00 08/15/22 12:00 EHAB Enhabit $16.08 / +2.27 (+16.44%) Enhabit is up 16.0%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly EHAB Enhabit $16.08 / +2.27 (+16.44%) 08/02/22 Enhabit falls -13.9% 08/02/22 Enhabit falls -13.3% 07/05/22 Enhabit to replace Loyalty Ventures in S&P 600 at open on 7/5 07/01/22 Encompass Health completes spin off of Enhabit EHAB Enhabit $16.08 / +2.27 (+16.44%) 08/08/22 Truist Encompass Health price target lowered to $65 from $75 at Truist 07/13/22 BofA BofA starts Enhabit at Underperform on Medicare rate risks 07/13/22 BofA Enhabit initiated with an Underperform at BofA EHAB Enhabit $16.08 / +2.27 (+16.44%) 08/01/22 Enhabit cuts FY22 EPS view to $1.47-$1.75 from $1.64-$2.01 08/01/22 Enhabit reports Q2 EPS 47c vs. 71c last year EHAB Enhabit $16.08 / +2.27 (+16.44%) 08/01/22 Fly Intel: After-Hours Movers 07/01/22 What You Missed On Wall Street On Friday 07/01/22 What You Missed On Wall Street This Morning

Hot Stocks	Blue Apron rises 20.7% » 12:00 08/15/22 08/15 12:00 08/15/22 12:00 APRN Blue Apron $4.60 / +0.795 (+20.89%) Blue Apron is up 20.7%,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options APRN Blue Apron $4.60 / +0.795 (+20.89%) 09:47 Today Blue Apron rises 11.5% 08/11/22 Blue Apron introduces new Tailgating Box 'in time for football season' 08/08/22 Blue Apron rises 17.8% 08/08/22 Blue Apron sees a route to revenue acceleration in the second half APRN Blue Apron $4.60 / +0.795 (+20.89%) 08/10/22 Lake Street Blue Apron initiated with a Buy at Lake Street 07/20/22 Benchmark Benchmark starts Blue Apron at Buy with turnaround not getting credit 07/20/22 Benchmark Blue Apron initiated with a Buy at Benchmark 05/10/22 Canaccord Blue Apron price target lowered to $10 from $12 at Canaccord APRN Blue Apron $4.60 / +0.795 (+20.89%) 08/08/22 Blue Apron cuts FY22 revenue growth view to 7%-13% vs. mid-teens 08/08/22 Blue Apron reports Q2 EPS (68c) vs. (98c) a year ago 05/10/22 Blue Apron targets revenue of $700M-plus in 2024 05/09/22 Blue Apron sees FY revenue growth in mid teens, one est. $532.3M APRN Blue Apron $4.60 / +0.795 (+20.89%) 05/10/22 Blue Apron shares going to $10 unless management 'sociopaths,' Citrons says APRN Blue Apron $4.60 / +0.795 (+20.89%) 08/12/22 Short Report: Bed Bath Beyond shorts nudge higher as stock soars 08/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 06/04/22 Short Report: GameStop short position reaches 15-month high 06/01/22 Fly Intel: After-Hours Movers 08/17/22 August Virtual Micro Cap Conference APRN Blue Apron $4.60 / +0.795 (+20.89%) 09:40 Today Unusually active option classes on open August 15th 07/07/22 Largest borrow rate increases among liquid names 06/24/22 Largest borrow rate increases among liquid names 06/23/22 Largest borrow rate increases among liquid names
Hot Stocks	Revlon rises 22.6% » 12:00 08/15/22 08/15 12:00 08/15/22 12:00 REV Revlon $8.05 / +1.48 (+22.53%) Revlon is up 22.6%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Periodicals On The Fly Options REV Revlon $8.05 / +1.48 (+22.53%) 08/09/22 Revlon CFO Victoria Dolan to retire, Matt Kvarda to become interim CFO 07/20/22 Origin Materials, Revlon enter carbon negative material joint initiative 07/01/22 Revlon rises 14.9% 07/01/22 Revlon rises 13.0% REV Revlon $8.05 / +1.48 (+22.53%) 05/04/22 Revlon reports Q1 EPS ($1.14) vs. ($1.55) last year 03/03/22 Revlon reports Q4 EPS 18c, one estimate 6c REV Revlon $8.05 / +1.48 (+22.53%) 06/21/22 Revlon's bankruptcy may be impacted by Citi's $900M error, FT reports 06/17/22 Indian conglomerate Reliance is considering to buy out Revlon, Reuters reports 06/10/22 Revlon preparing Chapter 11 filing as soon as next week, WSJ reports 06/10/22 Revlon nears Chapter 11 filing, WSJ reports, citing sources REV Revlon $8.05 / +1.48 (+22.53%) 08/12/22 Short Report: Bed Bath Beyond shorts nudge higher as stock soars 07/23/22 Short Report: Revlon shorts recede, stock retreats as buyout news fades 07/16/22 Short Report: Canoo shorts going along for the ride 06/18/22 Short Report: Short interest in crypto names spikes as bears pounce on bitcoin REV Revlon $8.05 / +1.48 (+22.53%) 08/02/22 Revlon call volume above normal and directionally bullish 08/02/22 Unusually active option classes on open August 2nd 08/01/22 Revlon call volume above normal and directionally bullish 07/29/22 Largest borrow rate increases among liquid names
Recommendations	Granite Real Estate price target raised to C$100 from C$99 at RBC Capital » 11:59 08/15/22 08/15 11:59 08/15/22 11:59 GRP Granite Real Estate $38.91 / + (+0.00%) RBC Capital analyst Pammi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research GRP Granite Real Estate $38.91 / + (+0.00%) 11:37 Today National Bank Granite Real Estate price target raised to C$90 from C$85 at National Bank 07/20/22 National Bank Granite Real Estate price target lowered to C$85 from C$115 at National Bank 05/16/22 Desjardins Granite Real Estate price target lowered to C$104 from C$111 at Desjardins 04/29/22 Scotiabank Granite Real Estate price target raised to C$110 from C$109 at Scotiabank
Recommendations	Akouos files IND for AK-OTOF, says Piper Sandler » 11:59 08/15/22 08/15 11:59 08/15/22 11:59 AKUS Akouos $3.43 / +0.35 (+11.36%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly AKUS Akouos $3.43 / +0.35 (+11.36%) 07:04 Today Akouos expects cash to fund operations beyond next eighteen months 05/19/22 Akouos presents nonclinical data on AK-OTOF, microRNA target sites 03/10/22 Akouos appoints Aaron Tward as CSO AKUS Akouos $3.43 / +0.35 (+11.36%) 05/17/22 Piper Sandler Akouos price target lowered to $18 from $40 at Piper Sandler AKUS Akouos $3.43 / +0.35 (+11.36%) 07:04 Today Akouos reports Q2 EPS (58c), consensus (76c) 05/12/22 Akouos reports Q1 EPS (78c), consensus (73c) 03/29/22 Akouos reports Q4 EPS (72c), consensus (66c) AKUS Akouos $3.43 / +0.35 (+11.36%) 08:56 Today Fly Intel: Pre-market Movers
Recommendations	Exchange Income price target raised to C$63 from C$62 at RBC Capital » 11:59 08/15/22 08/15 11:59 08/15/22 11:59 EIFZF Exchange Income $38.22 / +0.88 (+2.36%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research EIFZF Exchange Income $38.22 / +0.88 (+2.36%) 11:36 Today National Bank Exchange Income price target raised to C$61 from C$59 at National Bank 11:01 Today Scotiabank Exchange Income price target raised to C$60 from C$56 at Scotiabank 10:52 Today TD Securities Exchange Income price target raised to C$67 from C$59 at TD Securities 05/17/22 RBC Capital Exchange Income price target raised to C$62 from C$52 at RBC Capital
Recommendations	ECN Capital price target raised to C$8 from C$7.50 at RBC Capital » 11:57 08/15/22 08/15 11:57 08/15/22 11:57 ECNCF ECN Capital $5.57 / +0.384 (+7.40%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research ECNCF ECN Capital $5.57 / +0.384 (+7.40%) 08/12/22 BMO Capital ECN Capital price target raised to C$8 from C$7 at BMO Capital 08/12/22 Raymond James ECN Capital price target raised to C$8 from C$7 at Raymond James 08/12/22 National Bank ECN Capital price target raised to C$8.50 from C$8 at National Bank 08/09/22 TD Securities ECN Capital price target raised to C$8.50 from C$8 at TD Securities
Recommendations	Dialogue Health price target lowered to C$6 from C$7 at RBC Capital » 11:57 08/15/22 08/15 11:57 08/15/22 11:57 DLHTF Dialogue Health $2.30 / + (+0.00%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research DLHTF Dialogue Health $2.30 / + (+0.00%) 08/12/22 Scotiabank Dialogue Health price target lowered to C$8 from C$8.50 at Scotiabank 08/12/22 TD Securities Dialogue Health price target lowered to C$4.50 from C$5.50 at TD Securities 08/09/22 National Bank Dialogue Health price target lowered to C$8.50 from C$11.50 at National Bank
Recommendations	Chemtrade Logistics price target raised to C$10 from C$9 at RBC Capital » 11:56 08/15/22 08/15 11:56 08/15/22 11:56 CGIFF Chemtrade Logistics $7.17 / +0.06 (+0.84%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CGIFF Chemtrade Logistics $7.17 / +0.06 (+0.84%) 11:34 Today National Bank Chemtrade Logistics price target raised to C$11 from C$9.25 at National Bank 11:15 Today Desjardins Chemtrade Logistics price target raised to C$11.75 from C$11 at Desjardins 08/12/22 BMO Capital Chemtrade Logistics price target raised to C$9 from C$8 at BMO Capital 08/12/22 Scotiabank Chemtrade Logistics price target raised to C$10.50 from C$10.25 at Scotiabank
Hot Stocks	Novartis' treatment of Malaria granted FDA orphan designation » 11:56 08/15/22 08/15 11:56 08/15/22 11:56 NVS Novartis $85.05 / -0.63 (-0.74%) Novartis… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NVS Novartis $85.05 / -0.63 (-0.74%) 05:13 Today Novartis announces CANOPY-A trial did not meet primary endpoint 08/11/22 FDA grants regular approval to Novartis' capmatinib for metastatic NSCLC 08/08/22 Chimerix appoints Jordan as VP, Regulatory Affairs 07/28/22 Bausch Health to appeal expected court decision on certain Xifaxan patents NVS Novartis $85.05 / -0.63 (-0.74%) 08/05/22 Truist Global Blood could complement any oncology franchise, says Truist 08/04/22 Truist Truist sees Novartis, Vertex as logical suitors for Global Blood 07/20/22 JPMorgan Novartis price target raised to CHF 81 from CHF 80 at JPMorgan 07/20/22 Piper Sandler Piper adjusts Ionis' Spinraza royalties estimate following Biogen report NVS Novartis $85.05 / -0.63 (-0.74%) 07/19/22 Novartis reports Q2 core EPS $1.56 vs. $1.66 a year ago 04/26/22 Novartis sees 2022 core operating income to grow mid single digit 04/26/22 Novartis reports Q1 core EPS $1.46, consensus $1.46 NVS Novartis $85.05 / -0.63 (-0.74%) 08/11/22 Two died from acute liver failure after use of Novartis' Zolgensma, STAT says 06/30/22 Novartis favoring spinoff of $25B Sandoz unit, Bloomberg reports 06/30/22 Novartis said to lean toward Sandoz spinoff over sale, Bloomberg says 06/28/22 Novartis to cut up to 8,000 jobs, or 7% of workforce, in restructuring NVS Novartis $85.05 / -0.63 (-0.74%) 08/12/22 What You Missed On Wall Street This Morning 06/30/22 What You Missed On Wall Street On Thursday 06/30/22 What You Missed On Wall Street This Morning 06/28/22 What You Missed On Wall Street On Tuesday 09/10/22 ESMO Congress 2022 09/19/22 Novartis NVS Novartis $85.05 / -0.63 (-0.74%) 08/09/22 Largest borrow rate increases among liquid names
Recommendations	AG Growth International price target raised to C$55 from C$50 at RBC Capital » 11:56 08/15/22 08/15 11:56 08/15/22 11:56 AGGZF AG Growth International $30.82 / +1.01285 (+3.40%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research AGGZF AG Growth International $30.82 / +1.01285 (+3.40%) 11:11 Today Desjardins AG Growth International price target raised to C$53 from C$48 at Desjardins 08/12/22 Scotiabank AG Growth International price target raised to C$55 from C$52 at Scotiabank 04/20/22 Scotiabank AG Growth International price target raised to C$52 from C$50 at Scotiabank 03/17/22 RBC Capital AG Growth International price target raised to C$50 from C$45 at RBC Capital

Hot Stocks	Take-Two's Private Division to publish Middle-Earth game » 11:54 08/15/22 08/15 11:54 08/15/22 11:54 TTWO Take-Two $127.36 / +4.22 (+3.43%) Take-Two's Private… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TTWO Take-Two $127.36 / +4.22 (+3.43%) 09:06 Today Take-Two unit Private Division in publishing pact with Weta Workshop 08/09/22 Take-Two CEO: We're very confident in our upcoming titles 08/08/22 Take-Two delays 'Marvel's Midnight Suns' to fiscal 2023 08/02/22 U.S. video game consumer spending fell 13% y/y in Q2, says NPD TTWO Take-Two $127.36 / +4.22 (+3.43%) 08/10/22 DZ Bank Take-Two downgraded to Hold from Buy at DZ Bank 08/09/22 BofA BofA downgrades Take-Two, says risk/reward less appealing after Zynga deal 08/09/22 BofA Take-Two downgraded to Neutral from Buy at BofA 08/09/22 Oppenheimer Take-Two price target lowered to $180 from $190 at Oppenheimer TTWO Take-Two $127.36 / +4.22 (+3.43%) 08/08/22 Take-Two sees FY23 revenue $5.73B-$5.8B, consensus $6.32B 08/08/22 Take-Two reports Q2 EPS (76c) vs. $1.30 last year 05/16/22 Take-Two sees Q1 GAAP EPS 80c-90c, consensus 90c 05/16/22 Take-Two sees FY23 GAAP EPS $1.90-$2.15, consensus $5.99 TTWO Take-Two $127.36 / +4.22 (+3.43%) 07/21/22 Europe game sales rose 13.5% year-over-year in 1H22, Gamesindustry.biz says 07/11/22 Rockstar shelved plans for 'Red Dead 2' next-gen upgrade, VGC reports 07/05/22 Take-Two's Rockstar halts development of 'Red Dead,' 'GTA4' remakes, Kotaku says 04/14/22 'Elden Ring' top-selling game in Europe in March, Gamesindustry.biz says TTWO Take-Two $127.36 / +4.22 (+3.43%) 08/09/22 What You Missed This Week in Video Games 08/02/22 What You Missed This Week in Video Games 07/26/22 What You Missed This Week in Video Games 07/19/22 What You Missed This Week in Video Games 09/08/22 Consumer/Media/Entertainment Conference 09/16/22 Take-Two Interactive Software Inc. TTWO Take-Two $127.36 / +4.22 (+3.43%) 06/07/22 Early notable gainers among liquid option names on June 7th 05/25/22 Notable open interest changes for May 25th 05/17/22 Early notable gainers among liquid option names on May 17th 04/22/22 TakeTwo Interactive Software call volume above normal and directionally bullish
Hot Stocks	Taseko Mines reports EPA issues draft permit for Florence Copper Project » 11:54 08/15/22 08/15 11:54 08/15/22 11:54 TGB Taseko Mines $1.20 / +0.11 (+10.09%) Taseko Mines announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options TGB Taseko Mines $1.20 / +0.11 (+10.09%) 07/07/22 Taseko Mines updates status of copper price protection program 03/30/22 Taseko Mines announces 40% increase in Gibraltal Mine reserves TGB Taseko Mines $1.20 / +0.11 (+10.09%) 08/10/22 Scotiabank Taseko Mines price target lowered to C$1.75 from C$2 at Scotiabank 08/10/22 TD Securities Taseko Mines price target lowered to C$2.25 from C$2.50 at TD Securities 08/09/22 BMO Capital Taseko Mines price target lowered to C$2.50 from C$2.75 at BMO Capital 07/19/22 Stifel Taseko Mines price target lowered to C$2.50 from C$3.40 at Stifel TGB Taseko Mines $1.20 / +0.11 (+10.09%) 02/22/22 Taseko Mines options imply 11.3% move in share price post-earnings
Recommendations	Viridian Therapeutics price target raised to $50 from $40 at Evercore ISI » 11:51 08/15/22 08/15 11:51 08/15/22 11:51 VRDN Viridian Therapeutics $23.74 / +8.855 (+59.51%) Evercore ISI analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events VRDN Viridian Therapeutics $23.74 / +8.855 (+59.51%) 09:42 Today Viridian Therapeutics trading resumes 09:37 Today Viridian Therapeutics trading halted, volatility trading pause 07:07 Today Viridian Therapeutics- VRDN-001 shows efficacy in Phase 1/2 trial for TED 08/05/22 Viridian Therapeutics announces inducement grants under Nasdaq listing rule VRDN Viridian Therapeutics $23.74 / +8.855 (+59.51%) 06/23/22 B. Riley B. Riley starts Viridian Therapeutics at Buy with $25 price target 06/23/22 B. Riley Viridian Therapeutics initiated with a Buy at B. Riley 11/18/21 SVB Leerink Viridian Therapeutics initiated with an Outperform at SVB Leerink 11/05/21 JMP Securities Viridian Therapeutics price target lowered to $36 from $44 at JMP Securities VRDN Viridian Therapeutics $23.74 / +8.855 (+59.51%) 07:17 Today Viridian Therapeutics reports Q2 EPS ($1.06), consensus (90c) 05/12/22 Viridian Therapeutics reports Q1 EPS (98c), consensus ($1.08) 03/10/22 Viridian Therapeutics reports Q4 EPS ($1.32), consensus (90c) 21 Sep VRDN Viridian Therapeutics $23.74 / +8.855 (+59.51%) 08:56 Today Fly Intel: Pre-market Movers 08:00 Today Viridian Therapeutics - VRDN
General news	Treasury's $96 B 3- and 6-month auction results were generally poor » 11:50 08/15/22 08/15 11:50 08/15/22 11:50 $ECON Economic Data $0.00 / + (+0.00%) Treasury's $96 B 3-… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data $0.00 / + (+0.00%) 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data $0.00 / + (+0.00%) $ECON Economic Data $0.00 / + (+0.00%) 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data $0.00 / + (+0.00%) 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data $0.00 / + (+0.00%) 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
Periodicals	Sony's 'Horizon Forbidden West' still top seller in U.K., Gamesindustry.biz says » 11:48 08/15/22 08/15 11:48 08/15/22 11:48 SGAMY Sega Sammy Holdings $3.78 / +0.052 (+1.39%) , SONY Sony $86.65 / -0.1 (-0.12%) , NTDOY Nintendo $53.94 / + (+0.00%) , MSFT Microsoft $291.77 / -0.1 (-0.03%) , WBD Warner Bros. Discovery $13.53 / -0.15 (-1.10%) Sega's (SGAMY)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options SGAMY SONY NTDOY MSFT WBD SGAMY Sega Sammy Holdings $3.78 / +0.052 (+1.39%) 07/15/22 Bandai Namco's 'Elden Ring' best selling game in U.S. in June, says NPD 07/13/22 Sega Genesis Mini 2 out October 27, available exclusively through Amazon 04/20/22 Sega says remastered 'Sonic the Hedgehog' collection out June 23, 2022 03/11/22 Bandai Namco's 'Elden Ring' best-selling game in U.S. in February, says NPD SONY Sony $86.65 / -0.1 (-0.12%) 08/12/22 Warner Bros. Discovery's 'Hogwarts Legacy' game out February 10, 2023 08/08/22 Take-Two delays 'Marvel's Midnight Suns' to fiscal 2023 08/07/22 Fly Intel: Top five weekend stock stories 08/02/22 U.S. video game consumer spending fell 13% y/y in Q2, says NPD NTDOY Nintendo $53.94 / + (+0.00%) 08/12/22 Warner Bros. Discovery's 'Hogwarts Legacy' game out February 10, 2023 08/08/22 Take-Two delays 'Marvel's Midnight Suns' to fiscal 2023 08/03/22 Nintendo sold 3.43M Switch consoles in Q1 vs. 4.45M last year 08/02/22 U.S. video game consumer spending fell 13% y/y in Q2, says NPD MSFT Microsoft $291.77 / -0.1 (-0.03%) 08/12/22 Warner Bros. Discovery's 'Hogwarts Legacy' game out February 10, 2023 08/09/22 Barclays deploys Microsoft teams as collaboration platform 08/08/22 Take-Two delays 'Marvel's Midnight Suns' to fiscal 2023 08/04/22 Atlassian names Microsoft's Joe Binz as new CFO WBD Warner Bros. Discovery $13.53 / -0.15 (-1.10%) 07:16 Today Nexstar to acquire 75% ownership in The CW Network 08/12/22 Warner Bros. Discovery's 'Hogwarts Legacy' game out February 10, 2023 08/04/22 Warner Bros. Discovery backs long-term leverage target of 2.5-3.0 08/04/22 Warner Bros. Discovery sees FY23 adjusted EBITDA of 'at least $12B' SGAMY SONY NTDOY MSFT WBD SGAMY Sega Sammy Holdings $3.78 / +0.052 (+1.39%) SONY Sony $86.65 / -0.1 (-0.12%) 07/08/22 Macquarie Sony upgraded to Outperform, added to 'Marquee Buy' list at Macquarie 07/05/22 Citi Sony downgraded to Neutral from Buy at Citi 05/18/22 Oppenheimer Sony price target lowered to $125 from $150 at Oppenheimer 04/13/22 CLSA Sony downgraded to Outperform from Buy at CLSA NTDOY Nintendo $53.94 / + (+0.00%) 05/24/22 CLSA Nintendo price target lowered to 51,000 yen from 53,000 yen at CLSA 03/23/22 Macquarie Nintendo upgraded to Outperform from Neutral at Macquarie 02/16/22 Jefferies Nintendo upgraded to Buy from Hold at Jefferies 11/05/21 Macquarie Nintendo downgraded to Neutral from Outperform at Macquarie MSFT Microsoft $291.77 / -0.1 (-0.03%) 08/11/22 Guggenheim Microsoft initiated with a Neutral at Guggenheim 08/08/22 B. Riley B. Riley thinks Globalstar's mystery satellite capacity customer is Apple 08/04/22 MKM Partners 8x8 initiated with a Neutral at MKM Partners 08/04/22 Deutsche Bank Activision Blizzard price target lowered to $84 from $95 at Deutsche Bank WBD Warner Bros. Discovery $13.53 / -0.15 (-1.10%) 08/11/22 Wells Fargo Disney price target raised to $145 from $130 at Wells Fargo 08/10/22 Oppenheimer Trade Desk price target raised to $78 from $60 at Oppenheimer 08/08/22 Barrington Warner Bros. Discovery downgraded to Market Perform from Outperform at Barrington 08/05/22 Wells Fargo Warner Bros. Discovery downgraded to Equal Weight at Wells Fargo SONY NTDOY MSFT WBD SONY Sony $86.65 / -0.1 (-0.12%) 07/29/22 Sony raises FY22 consolidated sales view Y11.5T from Y11.4T 07/29/22 Sony reports Q1 revenue Y2.31T vs. Y2.26T last year 05/10/22 Sony sees FY22 consolidated sales Y11.4T vs. Y9.921B in FY21 05/10/22 Sony reports FY21 revenue Y9.921B vs. Y8.998B last year NTDOY Nintendo $53.94 / + (+0.00%) 08/03/22 Nintendo sees FY net sales Y1.6T, operating profit Y500B 08/03/22 Nintendo reports Q1 revenue Y307.46B vs. Y322.65B last year 05/10/22 Nintendo reports FY revenue Y1.70T vs. Y1.8T last year MSFT Microsoft $291.77 / -0.1 (-0.03%) 07/26/22 Microsoft sees FY23 revenue growth in double digits, consensus $225.98B 07/26/22 Microsoft reports Q4 EPS $2.23, consensus $2.30 07/26/22 Notable companies reporting after market close 06/02/22 Microsoft lowers Q4 EPS view to $2.24-$2.32 from $2.28-$2.35, consensus $2.33 WBD Warner Bros. Discovery $13.53 / -0.15 (-1.10%) 08/04/22 Warner Bros. Discovery cuts FY22 adjusted EBITDA view to $9.0B-$9.5B 08/04/22 Warner Bros. Discovery reports Q2 EPS with items ($1.50), consensus (3c) 08/04/22 Notable companies reporting after market close 04/26/22 Warner Bros. Discovery reports Q1 diluted EPS 69c vs. 21c a year ago SGAMY SONY NTDOY MSFT WBD SGAMY Sega Sammy Holdings $3.78 / +0.052 (+1.39%) 06/30/22 Sega eyes further expansion into live-action films, TV shows, IGN reports 04/19/22 Sega working on AAA reboots of 'Crazy Taxi,' 'Jet Set Radio,' Bloomberg says 04/04/22 'Sonic 2' film amasses $25.5M internationally, Gamesindustry.biz says SONY Sony $86.65 / -0.1 (-0.12%) 08/11/22 Game console sales fall 16% m/m in the U.K. in July, Gamesindustry.biz reports 08/11/22 Microsoft claims Sony pays developers to not put games on Game Pass, VGC says 08/10/22 Microsoft dismisses Sony claim that Activision deal is anticompetitive, VGC says 08/08/22 'Horizon Forbidden West' retakes top sales spot in U.K., Gamesindustry.biz says NTDOY Nintendo $53.94 / + (+0.00%) 08/11/22 Game console sales fall 16% m/m in the U.K. in July, Gamesindustry.biz reports 08/10/22 NLRB receives new workplace complaint against Nintendo, Axios reports 08/08/22 'Horizon Forbidden West' retakes top sales spot in U.K., Gamesindustry.biz says 08/04/22 Nintendo not releasing new hardware this fiscal year, Nikkei reports MSFT Microsoft $291.77 / -0.1 (-0.03%) 08/11/22 Game console sales fall 16% m/m in the U.K. in July, Gamesindustry.biz reports 08/11/22 Microsoft claims Sony pays developers to not put games on Game Pass, VGC says 08/10/22 Microsoft dismisses Sony claim that Activision deal is anticompetitive, VGC says 08/09/22 Microsoft lays off staff in Modern Life Experiences business, TechCrunch says WBD Warner Bros. Discovery $13.53 / -0.15 (-1.10%) 08/08/22 'Horizon Forbidden West' retakes top sales spot in U.K., Gamesindustry.biz says 08/05/22 Warner Bros. Discovery exploring free, ad-supported streaming, WSJ reports 08/04/22 Warner Bros. Discovery to combine HBO Max, Discovery+ next summer, Verge says 08/04/22 Warner Bros. Discovery to restructure HBO Max, Discovery+, TheWrap reports SGAMY SONY NTDOY MSFT WBD SGAMY Sega Sammy Holdings $3.78 / +0.052 (+1.39%) 07/19/22 What You Missed This Week in Video Games 07/12/22 What You Missed This Week in Video Games 06/28/22 What You Missed This Week in Video Games 06/22/22 What You Missed This Week in Video Games SONY Sony $86.65 / -0.1 (-0.12%) 08/09/22 What You Missed This Week in Video Games 08/07/22 Box Office Battle: ‘Bullet Train’ wins weekend with $30.1M debut 08/02/22 What You Missed This Week in Video Games 07/31/22 Box Office Battle: ‘DC League of Super-Pets’ wins weekend with $23M debut NTDOY Nintendo $53.94 / + (+0.00%) 08/09/22 What You Missed This Week in Video Games 08/02/22 What You Missed This Week in Video Games 07/26/22 What You Missed This Week in Video Games 07/19/22 What You Missed This Week in Video Games MSFT Microsoft $291.77 / -0.1 (-0.03%) 08/12/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/09/22 What You Missed On Wall Street On Tuesday 08/09/22 What You Missed This Week in Video Games 08/02/22 What You Missed This Week in Video Games WBD Warner Bros. Discovery $13.53 / -0.15 (-1.10%) 08/12/22 Sell these stocks now, proven algorithm says 08/08/22 What You Missed On Wall Street On Monday 08/08/22 What You Missed On Wall Street This Morning 08/08/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations MSFT WBD MSFT Microsoft $291.77 / -0.1 (-0.03%) 07/28/22 Notable open interest changes for July 28th 07/26/22 Microsoft options imply 4.7% move in share price post-earnings 06/03/22 Unusually active option classes on open June 3rd 06/02/22 Unusually active option classes on open June 2nd WBD Warner Bros. Discovery $13.53 / -0.15 (-1.10%) 08/12/22 Warner Bros Discovery Inc put volume heavy and directionally bearish 08/11/22 Early notable gainers among liquid option names on August 11th 08/09/22 Warner Bros Discovery Inc put volume heavy and directionally bearish 08/05/22 Notable open interest changes for August 5th

Events

Earnings calls, analyst events, roadshows and more

HCDI
Today at 12:30

Harbor Custom Development - HCDI Conference Calls
MCHP
Today at 13:00

Microchip - MCHP Conference Calls
BDC
Today at 13:00

Belden - BDC Conference Calls
DGX
Today at 13:00

Quest Diagnostics - DGX Conference Calls
REKR
Today at 13:00

Rekor Systems Inc Firm Sponsored Meetings

6721 Columbia Gateway Dr Suite 400, Columbia, MD
Today at 13:00

Natural Resources Industry Meetings
EBR
Today at 13:30

Eletrobras - EBR Conference Calls
DXYN
Today at 14:00

Dixie Group - DXYN Conference Calls
Today at 16:00

Treasury Int'l Capital: Net L-T Securities Transactions: June 2022 Government Event
TTOO
Today at 16:30

T2 Biosystems - TTOO Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	LUCY X LUCY Innovative Eyewear IPO Managers: Maxim Priced at: $7.50 980K Shares
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	GRFX X GRFX Graphex Group Secondary Managers: EF Hutton $2.00-3.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	GFRX X GFRX Graphex Group Secondary Managers: EF Hutton $2.00-3.00 8M Shares
Fri	No deals

View All Syndicate Announcements »

Roku price target lowered to $190 from $230 at Stephens

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access